|
1
|
Yoder M, Zhuge Y, Yuan Y, Holian O, Kuo S,
van Breemen R, Thomas LL and Lum H: Bioactive
lysophosphatidylcholine 16:0 and 18:0 are elevated in lungs of
asthmatic subjects. Allergy Asthma Immunol Res. 6:61–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohta K, Ichinose M, Nagase H, Yamaguchi M,
Sugiura H, Tohda Y, Yamauchi K, Adachi M and Akiyama K: Japanese
Society of Allergology: Japanese Guideline for Adult Asthma 2014.
Allergol Int. 63:293–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wells KE, Peterson EL, Ahmedani BK,
Severson RK, Gleason-Comstock J and Williams LK: The relationship
between combination inhaled corticosteroid and long-acting
β-agonist use and severe asthma exacerbations in a diverse
population. J Allergy Clin Immunol. 129:1274–1279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salpeter SR, Wall AJ and Buckley NS:
Long-acting beta-agonists with and without inhaled corticosteroids
and catastrophic asthma events. Am J Med. 123:322–328. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Global Initiative for Asthma: Global
strategy for asthma management and prevention. 2012, http://ginasthma.org/
|
|
6
|
Upur H, Yusufu A and Aimaiti N: New
interpretations of Abnormal Savda theory of traditional Uighur
Medicine. Xinjiang People's Press; Urumqi: 2009
|
|
7
|
Upur H, Maitisidike A, Aimaiti A
Feidasiyefu, Yiming Y and Dubrovin D: Diagnosis of abnormal humor
syndrome in traditional Uighur medicine and its prescriptions and
herbs. Xinjiang People's Press; Urumqi: 2013
|
|
8
|
Upur H, Dubrovin D, Amat N, Liu W, Moore
N, Bauer R, Suidre G, Gogol I, Dong J and Lapham JC:
Graeco-Arab-Uighur Medicine. Acupress; New York, NY: 2013
|
|
9
|
Halmurat U, Askar Y, Ilhamjan S, Obul K
and Roxangul S: Gene polymorphisms in Uighur patients with Abnormal
Savda. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 20:77–78. 2003.(In
Chinese). PubMed/NCBI
|
|
10
|
Tursun K, Asmtula D, Smayil M, Upur D and
Upur H: The relationship between asthma patients with abnormal
Savda in Uighur medicine and the gene polymorphism of IL-4.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:1076–1080. 2013.(In
Chinese). PubMed/NCBI
|
|
11
|
Yusup A and Upur H, Abla A and Upur H:
Association study of gene polymorphisms and depression with
abnormal humor in traditional Uighur medicine. BMC Complement
Altern Med. 13:3322013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Upur H, Yusup A, Umar A and Moore N:
Uighur traditional medicine syndrome of Abnormal Savda in men is
associated with oxidative stress, which can be improved by Munziq
and Mushil of Abnormal Savda. Therapie. 59:483–484. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amat N, Upur H, Ablimit A, Matsidik A,
Yusup A and Kijjoa A: Immunomodulatory effects of Abnormal Savda
Munsiq, a traditional Uighur medicine, on the combined stress mice.
J Ethnopharmacol. 122:42–47. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang YX, Abliz G, Ye WJ, Mutalipu Z, Li
XW, Wang HQ, Buranjiang G and Upur H: Mechanisms of hela cell
apoptosis induced by abnormal Savda Munziq total phenolics combined
with chemotherapeutic agents. Asian Pac J Cancer Prev. 15:743–747.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park CS and Rhim T: Application of
proteomics in asthma research. Expert Rev Proteomics. 8:221–230.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Neil SE, Sitkauskiene B, Babusyte A,
Krisiukeniene A, Stravinskaite-Bieksiene K, Sakalauskas R, Sihlbom
C, Ekerljung L, Carlsohn E and Lötvall J: Network analysis of
quantitative proteomics on asthmatic bronchi: Effects of inhaled
glucocorticoid treatment. Respir Res. 12:1242011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diagnostic criteria of the guide for
prevention and treatment of Bronchial Asthma, Chinese medical
association. Chin J Tuberculosis Respir Disease. 36:52013.
|
|
18
|
Boulet LP, FitzGerald JM, Levy ML, Cruz
AA, Pedersen S, Haahtela T and Bateman ED: A guide to the
translation of the global initiative for asthma (GINA) strategy
into improved care. Eur Respir J. 39:1220–1229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang H, Zhang X, Chi X, Wang J, Wang J
and Dou J: The effect of inhaled glucocorticoid therapy on serum
proteomics of asthmatic patients. Zhonghua Jie He He Hu Xi Za Zhi.
37:274–278. 2014.(In Chinese). PubMed/NCBI
|
|
20
|
Roh GS, Shin Y, Seo SW, Yoon BR, Yeo S,
Park SJ, Cho JW and Kwack K: Proteome analysis of differential
protein expression in allergen-induced asthmatic mice lung after
dexamethasone treatment. Proteomics. 4:3318–3327. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calvo F Quesada, Fillet M, Renaut J,
Crahay C, Gueders M, Hacha J, Paulissen G, Foidart JM, Noel A,
Rocks N, et al: Potential therapeutic target discovery by 2D-DIGE
proteomic analysis in mouse models of asthma. J Proteome Res.
10:4291–4301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Louten J, Mattson JD, Malinao MC, Li Y,
Emson C, Vega F, Wardle RL, van Scott MR, Fick RB, McClanahan TK,
et al: Biomarkers of disease and treatment in murine and cynomolgus
models of chronic asthma. Biomarker Insights. 7:87–104. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu Y, Batur M, Li W, Gao Z and Halmurat U:
Different syndromes in the same disease of bronchial asthma of
Uygur medicine abnormal savda syndrome based on metabonomics. J
Xinjiang Med Univ. 37:1441–1446. 2014.
|
|
24
|
Nazuk K, Batur M, Mavlanjan H, Denise D
and Halmurat U: Effect of Abnormal Savda Munziq on urine
metabolites from Abnormal Savda Syndrome carrying asthma rat model.
J Xinjiang Med University. 36:419–426. 2013.
|
|
25
|
Brinkmann C and Brixius K: Peroxiredoxins
and sports: New insights on the antioxidative defense. J Physiol
Sci. 63:1–5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwon HS, Bae YJ, Moon KA, Lee YS, Lee T,
Lee KY, Kim TB, Park CS, Moon HB and Cho YS: Hyperoxidized
peroxiredoxins in peripheral blood mononuclear cells of asthma
patients is associated with asthma severity. Life Sci. 90:502–508.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bajzar L, N esheim ME and Tracy PB: The
profibrinolytic effect of activated protein C in clots formed from
plasma is TAFI-dependent. Blood. 88:2093–2100. 1996.PubMed/NCBI
|
|
28
|
Leung LL, Myles T, Nishimura T, Song JJ
and Robinson WH: Regulation of tissue inflammation by
thrombin-activatable carboxypeptidase B (or TAFI). Mol Immunol.
45:4080–4083. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Andresen E, Lange C, Strodthoff D,
Goldmann T, Fischer N, Sahly H, Branscheid D and Heine H:
S100A7/psoriasin expression in the human lung: Unchanged in
patients with COPD, but upregulated upon positive S. aureus
detection. BMC Pulm Med. 11:102011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carlsson H, Yhr M, Petersson S, Collins N,
Polyak K and Enerbäck C: Psoriasin (S100A7) and calgranulin-B
(S100A9) induction is dependent on reactive oxygen species and is
downregulated by Bcl-2 and antioxidants. Cancer Biol Ther.
4:998–1005. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bryborn M, Adner M and Cardell LO:
Psoriasin, one of several new proteins identified in nasal lavage
fluid from allergic and non-allergic individuals using
2-dimensional gel electrophoresis and mass spectrometry. Respir
Res. 6:1182005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nasser MW, Qamri Z, Deol YS, Ravi J,
Powell CA, Trikha P, Schwendener RA, Bai XF, Shilo K, Zou X, et al:
S100A7 enhances mammary tumorigenesis through upregulation of
inflammatory pathways. Cancer Res. 72:604–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shubbar E, Vegfors J, Carlström M,
Petersson S and Enerbäck C: Psoriasin (S100A7) increases the
expression of ROS and VEGF and acts through RAGE to promote
endothelial cell proliferation. Breast Cancer Res Treat. 134:71–80.
2012. View Article : Google Scholar : PubMed/NCBI
|
